Howard Hughes Medical Institute’s Citigroup C Stock Holding History

Howard Hughes Medical Institute’s Portfolio C Stock Details C Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-386	Closed	-$45K	–	98
2025 Q4	$45K	Sell	386 -10	-3%	-$1.04K	0.03%	46
2025 Q3	$40.2K	Sell	396 -9	-2%	-$854	0.02%	51
2025 Q2	$34.5K	Buy	+405	New	+$29.3K	0.01%	59
2023 Q1	–	Sell	-150,000	Closed	-$6.78M	–	9
2022 Q4	$6.78M	Hold	150,000	–	–	3.78%	12
2022 Q3	$6.25M	Hold	150,000	–	–	1.78%	25
2022 Q2	$6.9M	Hold	150,000	–	–	3.73%	14
2022 Q1	$8.01M	Hold	150,000	–	–	3.51%	14
2021 Q4	$9.06M	Hold	150,000	–	–	3.55%	12
2021 Q3	$10.5M	Hold	150,000	–	–	3.55%	10
2021 Q2	$10.6M	Hold	150,000	–	–	3.55%	10
2021 Q1	$10.9M	Hold	150,000	–	–	3.72%	9
2020 Q4	$9.25M	Hold	150,000	–	–	2.16%	13
2020 Q3	$6.47M	Hold	150,000	–	–	2.13%	17
2020 Q2	$7.67M	Hold	150,000	–	–	3.13%	12
2020 Q1	$6.32M	Buy	150,000 +75,000	+100%	+$5.03M	1.32%	15
2019 Q4	$5.99M	Hold	75,000	–	–	2.15%	14
2019 Q3	$5.18M	Hold	75,000	–	–	1.45%	20
2019 Q2	$5.25M	Hold	75,000	–	–	2.51%	15
2019 Q1	$4.67M	Hold	75,000	–	–	1.09%	19
2018 Q4	$3.9M	Hold	75,000	–	–	1.24%	23
2018 Q3	$5.38M	Hold	75,000	–	–	1.57%	17
2018 Q2	$5.02M	Hold	75,000	–	–	1.27%	17
2018 Q1	$5.06M	Hold	75,000	–	–	1.32%	17
2017 Q4	$5.58M	Hold	75,000	–	–	1.45%	15
2017 Q3	$5.46M	Hold	75,000	–	–	1.35%	16
2017 Q2	$5.02M	Hold	75,000	–	–	0.91%	26
2017 Q1	$4.49M	Buy	+75,000	New	+$4.44M	0.83%	27
2016 Q4	–	Sell	-130,000	Closed	-$6.14M	–	151
2016 Q3	$6.14M	Hold	130,000	–	–	1.58%	19
2016 Q2	$5.51M	Sell	130,000 -30,891	-19%	-$1.37M	1.85%	17
2016 Q1	$6.72M	Sell	160,891 -79	-0%	-$3.3K	1.48%	11
2015 Q4	$8.33M	Buy	160,970 +31,909	+25%	+$1.69M	1.27%	8
2015 Q3	$6.4M	Sell	129,061 -9,167	-7%	-$501K	1.2%	13
2015 Q2	$7.64M	Sell	138,228 -40,398	-23%	-$2.2M	1.62%	8
2015 Q1	$9.2M	Buy	178,626 +3,558	+2%	+$181K	1.25%	5
2014 Q4	$9.47M	Buy	175,068 +40,068	+30%	+$2.13M	2.53%	5
2014 Q3	$7M	Hold	135,000	–	–	1.56%	14
2014 Q2	$6.36M	Buy	135,000 +14,711	+12%	+$700K	1.07%	17
2014 Q1	$5.73M	Sell	120,289 -1,662	-1%	-$82.8K	0.81%	22
2013 Q4	$6.36M	Buy	121,951 +2,140	+2%	+$108K	0.96%	21
2013 Q3	$5.81M	Sell	119,811 -3,205	-3%	-$162K	0.89%	24
2013 Q2	$5.9M	Buy	+123,016	New	+$5.91M	1.94%	20

Other funds holding C

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Howard Hughes Medical Institute's C Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Citigroup (C) in Q1 2026, closing a stake of 386 shares — an estimated $45K sold.

Howard Hughes Medical Institute first reported a position in C in Q2 2013 and held it in 41 quarters. The position peaked at $10.9M in Q1 2021. 2,456 funds tracked by Wall St. Rank hold C as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Citigroup position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 386 Citigroup shares in Q1 2026, an estimated $45K.
Howard Hughes Medical Institute first reported a position in Citigroup in Q2 2013 and held it in 41 quarters.
Howard Hughes Medical Institute's Citigroup position peaked at $10.9M in Q1 2021.
2,456 funds tracked by Wall St. Rank held Citigroup as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.